Study of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025
Public ClinicalTrials.gov record NCT02004392. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 26-Week Extension Study of the Safety and Clinical Effects of EVP-6124 in Subjects With Alzheimer's Disease Currently or Previously Receiving an Acetylcholinesterase Inhibitor Medication
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a 26-week, randomized extension of the Phase 3 double-blind placebo-controlled studies, EVP-6124-024 and EVP-6124-025. In this extension study, subjects who complete study EVP-6124-024 or EVP-6124-025 and fulfill all entry criteria will be randomized to receive EVP-6124 for an additional 26 weeks.
Study identification
- NCT ID
- NCT02004392
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 348 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 55 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2014 (Type not available)
- Primary completion
- Aug 2017 (Estimated)
- Completion
- Aug 2017 (Estimated)
- Last update posted
- May 3, 2016
2014 – 2017
United States locations
- U.S. sites
- 56
- U.S. states
- 26
- U.S. cities
- 56
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Phoenix | Arizona | — | — |
| Not listed | Tucson | Arizona | — | — |
| Not listed | Little Rock | Arkansas | — | — |
| Not listed | Costa Mesa | California | — | — |
| Not listed | Culver City | California | — | — |
| Not listed | Encino | California | — | — |
| Not listed | Glendale | California | — | — |
| Not listed | Long Beach | California | — | — |
| Not listed | Los Alamitos | California | — | — |
| Not listed | Orange | California | — | — |
| Not listed | Redding | California | — | — |
| Not listed | San Diego | California | — | — |
| Not listed | New Haven | Connecticut | — | — |
| Not listed | Norwich | Connecticut | — | — |
| Not listed | Atlantis | Florida | — | — |
| Not listed | Brooksville | Florida | — | — |
| Not listed | Delray Beach | Florida | — | — |
| Not listed | Fort Myers | Florida | — | — |
| Not listed | Hallandale | Florida | — | — |
| Not listed | Hialeah | Florida | — | — |
| Not listed | Jacksonville | Florida | — | — |
| Not listed | Leesburg | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Orlando | Florida | — | — |
| Not listed | Sunrise | Florida | — | — |
| Not listed | West Palm Beach | Florida | — | — |
| Not listed | Columbus | Georgia | — | — |
| Not listed | Park Ridge | Illinois | — | — |
| Not listed | Wichita | Kansas | — | — |
| Not listed | Baton Rouge | Louisiana | — | — |
| Not listed | Bangor | Maine | — | — |
| Not listed | Newton | Massachusetts | — | — |
| Not listed | Plymouth | Massachusetts | — | — |
| Not listed | Flowood | Mississippi | — | — |
| Not listed | Hattiesburg | Mississippi | — | — |
| Not listed | Creve Coeur | Missouri | — | — |
| Not listed | Princeton | New Jersey | — | — |
| Not listed | Springfield | New Jersey | — | — |
| Not listed | Albuquerque | New Mexico | — | — |
| Not listed | Brooklyn | New York | — | — |
| Not listed | Cedarhurst | New York | — | — |
| Not listed | Latham | New York | — | — |
| Not listed | Staten Island | New York | — | — |
| Not listed | Charlotte | North Carolina | — | — |
| Not listed | Wilmington | North Carolina | — | — |
| Not listed | Oklahoma City | Oklahoma | — | — |
| Not listed | Portland | Oregon | — | — |
| Not listed | Norristown | Pennsylvania | — | — |
| Not listed | Plains | Pennsylvania | — | — |
| Not listed | East Providence | Rhode Island | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Salt Lake City | Utah | — | — |
| Not listed | Bennington | Vermont | — | — |
| Not listed | Charlottesville | Virginia | — | — |
| Not listed | Williamsburg | Virginia | — | — |
| Not listed | Richland | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 30 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02004392, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 3, 2016 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02004392 live on ClinicalTrials.gov.